The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.
about
Management of patients with hepatitis B in special populationsAASLD guidelines for treatment of chronic hepatitis B.Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis.Can We Trust Safety of Tenofovir Disoproxil in Patients with Decompensated Cirrhosis?Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.
P2860
The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The impact of newer nucleos
@nl
The impact of newer nucleos(t) ...... tis B decompensated cirrhosis.
@ast
The impact of newer nucleos(t) ...... tis B decompensated cirrhosis.
@en
type
label
The impact of newer nucleos
@nl
The impact of newer nucleos(t) ...... tis B decompensated cirrhosis.
@ast
The impact of newer nucleos(t) ...... tis B decompensated cirrhosis.
@en
prefLabel
The impact of newer nucleos
@nl
The impact of newer nucleos(t) ...... tis B decompensated cirrhosis.
@ast
The impact of newer nucleos(t) ...... tis B decompensated cirrhosis.
@en
P2093
P2860
P1476
The impact of newer nucleos(t) ...... tis B decompensated cirrhosis.
@en
P2093
Anastasios Karlaftis
Evangelos Akriviadis
Evangelos Cholongitas
George Kontos
George V Papatheodoridis
John Goulis
John Ketikoglou
John Vlachogiannakos
Stylianos Karatapanis
Themistoklis Vasiliadis
P2860
P304
P577
2015-01-01T00:00:00Z